Paper36992136
Impact of MERS-CoV and SARS-CoV-2 Viral Infection on Immunoglobulin-IgG Cross-Reactivity.
AlKhalifah JM and 7 others. Vaccines (Basel), 2023. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. Impact of MERS-CoV and SARS-CoV-2 Viral Infection on Immunoglobulin-IgG Cross-Reactivity. Papers, record 36992136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36992136
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Impact of MERS-CoV and SARS-CoV-2 Viral Infection on Immunoglobulin-IgG Cross-Reactivity.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| RSP 2023 R 47 | King Saud University, Riyadh, Saudi Arabia | PubMed |
Source PubMed
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33159009 | Preexisting and de novo humoral immunity to SARS-CoV-2 in humans. | Science | 2020 | https://conductscience.org/library/papers/33159009 | PubMed |
| 2 | 31978945 | A Novel Coronavirus from Patients with Pneumonia in China, 2019. | N Engl J Med | 2020 | https://conductscience.org/library/papers/31978945 | PubMed |
| 3 | 36539527 | The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses. | Nat Rev Immunol | 2023 | https://conductscience.org/library/papers/36539527 | PubMed |
| 4 | 32344314 | Innate immunity in COVID-19 patients mediated by NKG2A receptors, and potential treatment using Monalizumab, Cholroquine, and antiviral agents. | Med Hypotheses | 2020 | https://conductscience.org/library/papers/32344314 | PubMed |
| 5 | 19239338 | Human coronavirus and acute respiratory illness in older adults with chronic obstructive pulmonary disease. | J Infect Dis | 2009 | https://conductscience.org/library/papers/19239338 | PubMed |
| 6 | 27287409 | Airway Memory CD4(+) T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses. | Immunity | 2016 | https://conductscience.org/library/papers/27287409 | PubMed |
| 7 | 33320447 | Evidence and implications of pre-existing humoral cross-reactive immunity to SARS-CoV-2. | Immun Inflamm Dis | 2021 | https://conductscience.org/library/papers/33320447 | PubMed |
| 8 | 36713397 | The impact of cross-reactive immunity on the emergence of SARS-CoV-2 variants. | Front Immunol | 2022 | https://conductscience.org/library/papers/36713397 | PubMed |
| 9 | 22673931 | Differences in neutralizing antigenicity between laboratory and clinical isolates of HCoV-229E isolated in Japan in 2004-2008 depend on the S1 region sequence of the spike protein. | J Gen Virol | 2012 | https://conductscience.org/library/papers/22673931 | PubMed |
| 10 | 23782161 | Hospital outbreak of Middle East respiratory syndrome coronavirus. | N Engl J Med | 2013 | https://conductscience.org/library/papers/23782161 | PubMed |
| 11 | 32758887 | Cross-immunity between respiratory coronaviruses may limit COVID-19 fatalities. | Med Hypotheses | 2020 | https://conductscience.org/library/papers/32758887 | PubMed |
| 12 | 34603300 | Potential Cross-Reactive Immunity to COVID-19 Infection in Individuals With Laboratory-Confirmed MERS-CoV Infection: A National Retrospective Cohort Study From Saudi Arabia. | Front Immunol | 2021 | https://conductscience.org/library/papers/34603300 | PubMed |
| 13 | 19342289 | Examination of seroprevalence of coronavirus HKU1 infection with S protein-based ELISA and neutralization assay against viral spike pseudotyped virus. | J Clin Virol | 2009 | https://conductscience.org/library/papers/19342289 | PubMed |
| 14 | 32898238 | Sustained Responses of Neutralizing Antibodies Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Recovered Patients and Their Therapeutic Applicability. | Clin Infect Dis | 2021 | https://conductscience.org/library/papers/32898238 | PubMed |
| 15 | 29263263 | Identification of Residues Controlling Restriction versus Enhancing Activities of IFITM Proteins on Entry of Human Coronaviruses. | J Virol | 2018 | https://conductscience.org/library/papers/29263263 | PubMed |
| 16 | 16479513 | Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome. | J Infect Dis | 2006 | https://conductscience.org/library/papers/16479513 | PubMed |
| 17 | 23075143 | Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. | N Engl J Med | 2012 | https://conductscience.org/library/papers/23075143 | PubMed |
| 18 | 34260272 | Performance of the Abbott SARS-CoV-2 IgG II Quantitative Antibody Assay Including the New Variants of Concern, VOC 202012/V1 (United Kingdom) and VOC 202012/V2 (South Africa), and First Steps towards Global Harmonization of COVID-19 Antibody Methods. | J Clin Microbiol | 2021 | https://conductscience.org/library/papers/34260272 | PubMed |
| 19 | 29864486 | Healthcare-associated infections: the hallmark of Middle East respiratory syndrome coronavirus with review of the literature. | J Hosp Infect | 2019 | https://conductscience.org/library/papers/29864486 | PubMed |
| 20 | 32073157 | Antibodies to coronaviruses are higher in older compared with younger adults and binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus-associated illnesses. | J Med Virol | 2020 | https://conductscience.org/library/papers/32073157 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42328241 | Original Antigenic Sin on Antibody Response in SARS-CoV-2 Infection. | Infect Dis Immun | 2024 | https://conductscience.org/library/papers/42328241 | PubMed |
| 41274935 | Colostrum from MERS-CoV seropositive camels for MERS prophylaxis and SARS-CoV-2 infection, a placebo controlled randomized trial. | Sci Rep | 2025 | https://conductscience.org/library/papers/41274935 | PubMed |
| 40774254 | Highly conserved Betacoronavirus sequences are broadly recognized by human T cells. | Cell | 2025 | https://conductscience.org/library/papers/40774254 | PubMed |
| 40455375 | Recurrent MERS-CoV Transmission in Saudi Arabia- Renewed Lessons in Healthcare Preparedness and Surveillance. | J Epidemiol Glob Health | 2025 | https://conductscience.org/library/papers/40455375 | PubMed |
| 40359129 | Comprehensive analysis of human coronavirus antibody responses in ICU and non-ICU COVID-19 patients reveals IgG3 against SARS-CoV-2 spike protein as a key biomarker of disease severity. | J Med Microbiol | 2025 | https://conductscience.org/library/papers/40359129 | PubMed |
| 39822038 | A 10 Year Long-Lived Cellular and Humoral MERS-CoV Immunity Cross-Recognizing the Wild-Type and Variants of SARS-CoV-2: A Potential One-Way MERS-CoV Cross-Protection Toward a Pan-Coronavirus Vaccine. | J Med Virol | 2025 | https://conductscience.org/library/papers/39822038 | PubMed |
| 39288758 | Gestational SARS-CoV-2 Infection in a Ugandan Birth Cohort: High Incidence, Mild Maternal Disease, and Evidence of Association with Transient Infant Stunting. | Am J Trop Med Hyg | 2024 | https://conductscience.org/library/papers/39288758 | PubMed |
| 39125749 | Enhanced Assessment of Cross-Reactive Antigenic Determinants within the Spike Protein. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39125749 | PubMed |
| 38543668 | Back to the Future: Immune Protection or Enhancement of Future Coronaviruses. | Microorganisms | 2024 | https://conductscience.org/library/papers/38543668 | PubMed |
| 38448564 | Neutralizing immunity against coronaviruses in Tanzanian health care workers. | Sci Rep | 2024 | https://conductscience.org/library/papers/38448564 | PubMed |
| 38416834 | Rise in broadly cross-reactive adaptive immunity against human β-coronaviruses in MERS-recovered patients during the COVID-19 pandemic. | Sci Adv | 2024 | https://conductscience.org/library/papers/38416834 | PubMed |
| 37777266 | The role of cross-reactive immunity to emerging coronaviruses: Implications for novel universal mucosal vaccine design. | Saudi Med J | 2023 | https://conductscience.org/library/papers/37777266 | PubMed |
| 37242383 | Unravelling Antigenic Cross-Reactions toward the World of Coronaviruses: Extent of the Stability of Shared Epitopes and SARS-CoV-2 Anti-Spike Cross-Neutralizing Antibodies. | Pathogens | 2023 | https://conductscience.org/library/papers/37242383 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| IFNG | 3458 | PubTator's text mining | https://conductscience.org/library/genes/3458 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36992136
GET https://conductscience.org/api/papers/v1/36992136/references?page=2